Indiana legislation · 2025 Regular Session
Indiana SB118: 340B drug program report.
Status: Chaptered, May 6, 2025
340B drug program report. Requires certain entities authorized to participate in the federal 340B Drug Pricing Program to annually report specified data to the Indiana department of health (state department). Requires the state department to submit a report of the aggregated data to the legislative council and post the report on the state department's website.
Sponsors
- Ed Charbonneau (R, SD-005) · primary sponsor
- Michael Crider (R, SD-028) · primary sponsor
- Tyler Johnson (R, SD-014) · primary sponsor
- Spencer Deery (R, SD-023)
- Vaneta Becker (R, SD-050)
- Justin Busch (R, SD-016)
- Barrett, Brad (R)
- Julie McGuire (R, HD-093)
- Tony Isa (R, HD-051)
- Lori Goss-Reaves (R, HD-031)
Votes
- Senate - Conference Committee Report 1 (April 23, 2025): 48 yea, 0 nay, passed
- House - Rules Suspended. Conference Committee Report 1 (April 23, 2025): 89 yea, 2 nay, passed
- House - Third reading (April 1, 2025): 91 yea, 1 nay, passed
- Senate - Third reading (February 4, 2025): 49 yea, 1 nay, passed
Common questions
- What is SB118?
- SB118 is a bill in the Indiana Legislature (2025 Regular Session): 340B drug program report.
- What does SB118 do?
- 340B drug program report. Requires certain entities authorized to participate in the federal 340B Drug Pricing Program to annually report specified data to the Indiana department of health (state department). Requires the state department to submit a report of the aggregated data to the legislative council and post the report on the state department's website.
- What is the status of SB118?
- Chaptered as of May 6, 2025.
- Who sponsored SB118?
- Ed Charbonneau (R, SD-005), with 9 co-sponsors.
- Where is the official record for SB118?
- On the Indiana Legislature website: https://iga.in.gov/legislative/2025/bills/senate/118/details
Source: official Indiana record. Tracked by Delilah, AI for legislation across all 50 states and Congress.